[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Analytics Market by Type (Descriptive, Predictive, Cognitive), Application (Financial, RCM, Fraud, Clinical, Operational), Component (Services, Software), Deployment (on premise, Cloud), End-user (Hospitals, Payer) - Global Forecast to 2027

December 2022 | 323 pages | ID: HE9D1CDBF09EN
MarketsandMarkets

US$ 3,465.00 US$ 4,950.00 -30 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global healthcare analytics market is projected to reach USD 85.9 billion by 2027 from USD 27.4 billion in 2022, at a CAGR of 25.7% during the forecast period. The healthcare analytics market is mainly driven by factors such as increasing amount of venture capital investments and implementation of federal health mandates that encourage the adoption of HCIT solutions. However, poorly connected IT infrastructure, data security issues, and low budget allocations of hospitals for implementing HCIT solutions are likely to restrain growth of this market.

Descriptive analytics type segment holds the largest share of the healthcare analytics market in 2021”

On the basis of type, the market is segmented into cognitive analytics, descriptive analytics, predictive analytics, and prescriptive analytics. In 2021, the descriptive analytics segment hold the largest share of the healthcare analytics market. The large share of this segment is primarily attributed because descriptive analytics help healthcare payers and providers to enhance and manage their business practices.

Clinical analytics segment is expected to grow at the highest rate during the forecast period

On the basis of application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operational & administrative analytics, and population health analytics. In 2021, the financial analytics segment hold the largest share of the healthcare analytics market, while the clinical analytics segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing pressure to curb healthcare costs, and federal mandates such as the implementation of ICD-10 code sets.

Services segment to hold the largest share of the healthcare analytics market

On the basis of component, the healthcare analytics market is segmented into services, hardware, and software. In 2021, the services segment accounted for the largest market share of healthcare analytics market. Factors such as end users of healthcare analytics depend on service providers for consulting, data storage, implementing services, and regular solution upgrades.

On-premise segment is expected to account for the largest share of the healthcare analytics market

On the basis of deployment model, the market is segmented into on-premise and on-demand. In 2022, on-premise segment is estimated to account for the largest share of the healthcare analytics market. The large share of this segment is primarily attributed because on-premise deployment allows end users to make use of solutions from multiple vendors, which allows customizations as per end-user requirements.

Payers segments hold the largest share of the healthcare analytics in 2021, by end user

On the basis of end users, the healthcare analytics market is segmented into providers (hospitals, physician practices, IDN, post-acute care organisations and, ambulatory settings), payers (private insurance companies, government agencies, and employers & private exchangers), and ASCOs, HIEs, & TPAs. In 2021, the payers segment holds the largest share of the healthcare analytics market. Factors such as the increasing need to curb fraudulent claims and minimize the operational price is the key factor driving the growth of this segment.

North America to be the largest and the fastest-growing regional market

North America, which includes the US and Canada, holds the largest market share for healthcare analytics market in 2021. Factors such as most of the leading players in the healthcare analytics market have their headquarters in North America, technological advancements, and high product and service availability in this region.

Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 37%, Tier 2 – 22%, and Tier 3 – 41% • By Designation: Director-level – 25%, C-level – 20%, and Others – 55% • By Region: North America - 40%, Europe – 27%, APAC –20%, Rest of the World –13%

Prominent players in this market include IBM (US), SAS Institute Inc. (US), Optum, Inc. (US), Cerner Corporation (US), Allscripts Healthcare, LLC (US), Cotiviti, Inc. (US), CitiusTech Inc (US), Health Catalyst (US), CVS Health (US), Inovalon (US), McKesson Corporation (US), MedeAnalytics, Inc. (US), Oracle (US), ExlService Holdings, Inc. (US), Gainwell (US), Wipro (US), Flatiron (US), Apixio (US), Enlitic, Inc. (US), Komodo Health, Inc. (US), HealthEC, LLC, Sema4 OpCo, Inc. (US), Evidation Health, Inc. (US), Insilico Medicine (US), Exscientia (UK), Aetion, Inc.(US), and Premier (US).

Research Coverage

This report studies the healthcare analytics market based on type, application, component, deployment model, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies – source and destination.

Key Benefits of Buying the Report

This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS AND EXCLUSIONS
  1.2.2 MARKETS COVERED
FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION
  1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
  2.2.1 SECONDARY RESEARCH
    2.2.1.1 Key data from secondary sources
  2.2.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
    2.2.2.1 Key data from primary sources
    2.2.2.2 Insights from primary experts
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 7 REVENUE ANALYSIS OF TOP THREE PUBLIC COMPANIES: HEALTHCARE ANALYTICS MARKET (2021)
FIGURE 8 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF HEALTHCARE ANALYTICS (US)
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 11 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 12 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
  2.7.1 METHODOLOGY-RELATED LIMITATIONS
  2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: HEALTHCARE ANALYTICS MARKET

3 EXECUTIVE SUMMARY

FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
FIGURE 16 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2022 VS. 2027 (USD MILLION)
FIGURE 17 HEALTHCARE ANALYTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICS MARKET

4 PREMIUM INSIGHTS

4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW
FIGURE 19 GOVERNMENT INITIATIVES TO INCREASE EHR ADOPTION AND CURB HEALTHCARE COSTS
4.2 FINANCIAL ANALYTICS MARKET SHARE, BY TYPE AND REGION (2021)
FIGURE 20 NORTH AMERICA HELD LARGEST SHARE OF FINANCIAL ANALYTICS MARKET IN 2021
4.3 HEALTHCARE ANALYTICS MARKET: GROWTH RATES
FIGURE 21 US TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.4 REGIONAL MIX: HEALTHCARE ANALYTICS MARKET
FIGURE 22 NORTH AMERICA DOMINATED MARKET IN 2021

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 DRIVERS
    5.2.1.1 Government initiatives to increase EHR adoption
FIGURE 24 EHR ADOPTION RATE AMONG HOSPITALS AND PHYSICIANS (2015–2021)
    5.2.1.2 Growing venture capital investments in healthcare analytics start-ups
    5.2.1.3 Growing pressure to curb healthcare spending and improve patient outcomes
FIGURE 25 HEALTHCARE SPENDING AS PERCENTAGE OF GDP, BY COUNTRY, 2019
    5.2.1.4 Heterogeneity and complexity of big data in healthcare
    5.2.1.5 Growing focus on real-world evidence
  5.2.2 RESTRAINTS
    5.2.2.1 High cost of analytics solutions in healthcare organizations
    5.2.2.2 Rising data breach concerns
  5.2.3 OPPORTUNITIES
    5.2.3.1 Increasing focus on value-based medicines
    5.2.3.2 Use of analytics in precision and personalized medicines
    5.2.3.3 Cloud-based analytics
    5.2.3.4 Increasing number of patient registries
    5.2.3.5 Emergence of social media and its impact on healthcare industry
    5.2.3.6 Augmented analytics to supplement human intelligence
    5.2.3.7 Growing adoption of internet of healthcare things (IoHT)
  5.2.4 CHALLENGES
    5.2.4.1 Concerns regarding inaccurate and inconsistent data
    5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
    5.2.4.3 Data integration for coordinated care
    5.2.4.4 Operational gaps between payers and providers
    5.2.4.5 Dearth of skilled personnel
5.3 ECOSYSTEM ANALYSIS
FIGURE 26 ECOSYSTEM ANALYSIS: HEALTHCARE ANALYTICS MARKET
5.4 VALUE CHAIN ANALYSIS
FIGURE 27 VALUE CHAIN ANALYSIS: HEALTHCARE ANALYTICS MARKET
5.5 CASE STUDY ANALYSIS
  5.5.1 CASE STUDY 1
  5.5.2 CASE STUDY 2
  5.5.3 CASE STUDY 3
  5.5.4 CASE STUDY 4
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 PORTER’S FIVE FORCES ANALYSIS: HEALTHCARE ANALYTICS MARKET
  5.6.1 THREAT FROM NEW ENTRANTS
  5.6.2 THREAT FROM SUBSTITUTES
  5.6.3 BARGAINING POWER OF SUPPLIERS
  5.6.4 BARGAINING POWER OF BUYERS
  5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 REGULATORY ANALYSIS
  5.7.1 NORTH AMERICA
  5.7.2 EUROPE
  5.7.3 ASIA PACIFIC
  5.7.4 MIDDLE EAST & AFRICA
  5.7.5 LATIN AMERICA
5.8 TECHNOLOGY ANALYSIS
  5.8.1 MACHINE LEARNING
  5.8.2 ARTIFICIAL INTELLIGENCE
  5.8.3 INTERNET OF THINGS
  5.8.4 BLOCKCHAIN
  5.8.5 BIG DATA
5.9 INDUSTRY TRENDS
  5.9.1 INCREASING PARTNERSHIPS AND COLLABORATIONS FOR INNOVATION
  5.9.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
  5.9.3 CLOUD-BASED IT SOLUTIONS
5.10 PRICING ANALYSIS
TABLE 3 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY APPLICATION
5.11 AVERAGE SELLING PRICE TREND ANALYSIS
5.12 PATENT ANALYSIS
FIGURE 28 PATENT ANALYSIS: HEALTHCARE ANALYTICS MARKET (JANUARY 2017–SEPTEMBER 2022)
  5.12.1 PATENTS: HEALTHCARE ANALYTICS MARKET
5.13 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 4 HEALTHCARE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
  5.14.2 BUYING CRITERIA
FIGURE 30 KEY BUYING CRITERIA FOR END USERS
TABLE 6 KEY BUYING CRITERIA FOR END USERS

6 HEALTHCARE ANALYTICS MARKET, BY TYPE

6.1 INTRODUCTION
TABLE 7 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 DESCRIPTIVE ANALYTICS
  6.2.1 DESCRIPTIVE ANALYTICS TO CONVERT PAST DATA INTO USEFUL INFORMATION
TABLE 8 HEALTHCARE ANALYTICS MARKET FOR DESCRIPTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
6.3 PREDICTIVE ANALYTICS
  6.3.1 GROWING USE OF PREDICTIVE ANALYTICS TO IDENTIFY HIGH-RISK PATIENTS TO DRIVE GROWTH
TABLE 9 HEALTHCARE ANALYTICS MARKET FOR PREDICTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
6.4 PRESCRIPTIVE ANALYTICS
  6.4.1 PRESCRIPTIVE ANALYTICS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
TABLE 10 HEALTHCARE ANALYTICS MARKET FOR PRESCRIPTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
6.5 COGNITIVE ANALYTICS
  6.5.1 INTRODUCTION OF AI-DRIVEN ANALYTICS SOLUTIONS TO BOOST MARKET
TABLE 11 HEALTHCARE ANALYTICS MARKET FOR COGNITIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)

7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT

7.1 INTRODUCTION
TABLE 12 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
7.2 SERVICES
TABLE 13 HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 14 HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION)
  7.2.1 SUPPORT SERVICES
    7.2.1.1 Support services to include implementation, ongoing IT support, system integration, training, and maintenance services
TABLE 15 HEALTHCARE ANALYTICS SUPPORT SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
  7.2.2 BUSINESS ANALYTICS SERVICES
    7.2.2.1 Business analytics services to help healthcare organizations optimize use of analytics and drive performance improvement
TABLE 16 HEALTHCARE BUSINESS ANALYTICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3 SOFTWARE
  7.3.1 HEALTHCARE ANALYTICS SOFTWARE TO WORK AS INTERFACE BETWEEN DATABASE AND END USERS
TABLE 17 HEALTHCARE ANALYTICS MARKET FOR SOFTWARE, BY REGION, 2020–2027 (USD MILLION)
7.4 HARDWARE
  7.4.1 INCREASING ADOPTION OF CLOUD SERVERS TO HINDER GROWTH
TABLE 18 HEALTHCARE ANALYTICS MARKET FOR HARDWARE, BY REGION, 2020–2027 (USD MILLION)

8 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL

8.1 INTRODUCTION
TABLE 19 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
8.2 ON-PREMISE DEPLOYMENT
  8.2.1 MULTIVENDOR ARCHITECTURE TO LOWER RISK OF DATA BREACHES AND EXTERNAL ATTACKS
TABLE 20 ON-PREMISE SOLUTIONS AVAILABLE
TABLE 21 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE DEPLOYMENT MODEL, BY REGION, 2020–2027 (USD MILLION)
8.3 ON-DEMAND DEPLOYMENT
  8.3.1 INCREASING VOLUME OF DATA GENERATED TO DRIVE ADOPTION
TABLE 22 ON-DEMAND SOLUTIONS AVAILABLE
TABLE 23 HEALTHCARE ANALYTICS MARKET FOR ON-DEMAND DEPLOYMENT MODEL, BY REGION, 2020–2027 (USD MILLION)

9 HEALTHCARE ANALYTICS MARKET, BY APPLICATION

9.1 INTRODUCTION
TABLE 24 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2 FINANCIAL ANALYTICS
TABLE 25 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS
TABLE 26 HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 27 HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
  9.2.1 CLAIMS PROCESSING
    9.2.1.1 Improvement in claims response time and avoidance of fraudulent claims to support market
TABLE 28 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS
TABLE 29 HEALTHCARE ANALYTICS MARKET FOR CLAIMS PROCESSING, BY REGION, 2020–2027 (USD MILLION)
  9.2.2 REVENUE CYCLE MANAGEMENT
    9.2.2.1 Healthcare organizations to adopt predictive analytics solutions for proactive decision-making
TABLE 30 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS
TABLE 31 HEALTHCARE ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2020–2027 (USD MILLION)
  9.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE (FWA)
    9.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to boost market
TABLE 32 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS
TABLE 33 HEALTHCARE ANALYTICS MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2020–2027 (USD MILLION)
  9.2.4 RISK ADJUSTMENT & ASSESSMENT
    9.2.4.1 Optimization of cash flows and improved financial performance to aid market
TABLE 34 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS
TABLE 35 HEALTHCARE ANALYTICS MARKET FOR RISK ADJUSTMENT & ASSESSMENT, BY REGION, 2020–2027 (USD MILLION)
9.3 CLINICAL ANALYTICS
TABLE 36 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS
TABLE 37 HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 38 HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
  9.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
    9.3.1.1 Benchmarking to identify and manage issues that negatively impact healthcare systems
TABLE 39 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS
TABLE 40 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING MARKET, BY REGION, 2020–2027 (USD MILLION)
  9.3.2 CLINICAL DECISION SUPPORT
    9.3.2.1 Reduction of medical errors and performance of appropriate tests to augment market
TABLE 41 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT
TABLE 42 CLINICAL DECISION SUPPORT MARKET, BY REGION, 2020–2027 (USD MILLION)
  9.3.3 REPORTING & COMPLIANCE
    9.3.3.1 Stringent regulatory requirements to accelerate market
TABLE 43 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE
TABLE 44 REPORTING & COMPLIANCE MARKET, BY REGION, 2020–2027 (USD MILLION)
  9.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
    9.3.4.1 Growing adoption of EHRs to provide growth
TABLE 45 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS
TABLE 46 COMPARATIVE ANALYTICS/EFFECTIVENESS MARKET, BY REGION, 2020–2027 (USD MILLION)
  9.3.5 PRECISION HEALTH
    9.3.5.1 Strong government support for personalized medicine to drive market
TABLE 47 COMMERCIALLY AVAILABLE PRECISION HEALTH SOLUTIONS
TABLE 48 PRECISION HEALTH MARKET, BY REGION, 2020–2027 (USD MILLION)
  9.3.6 MEDICAL IMAGING ANALYTICS
    9.3.6.1 Imaging analytics aided by artificial intelligence and machine learning to fuel market
TABLE 49 COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS
TABLE 50 MEDICAL IMAGING ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
TABLE 51 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS
TABLE 52 HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
  9.4.1 SUPPLY CHAIN ANALYTICS
    9.4.1.1 Informed decisions about costs, medication, and equipment to propel market
TABLE 54 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS
TABLE 55 SUPPLY CHAIN ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
  9.4.2 WORKFORCE ANALYTICS
    9.4.2.1 Need for real-time resource demand and supply data to drive adoption of workforce analytics
TABLE 56 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS
TABLE 57 WORKFORCE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
  9.4.3 STRATEGIC ANALYTICS
    9.4.3.1 Strategic analytics to use advanced analytics tools and leverage operational data
TABLE 58 STRATEGIC ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.5 POPULATION HEALTH ANALYTICS
  9.5.1 IMPROVING POPULATION HEALTH OUTCOMES AND LOWERING COSTS TO DRIVE GROWTH
TABLE 59 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS
TABLE 60 HEALTHCARE ANALYTICS MARKET FOR POPULATION HEALTH ANALYTICS, BY REGION, 2020–2027 (USD MILLION)

10 HEALTHCARE ANALYTICS MARKET, BY END USER

10.1 INTRODUCTION
TABLE 61 HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2 PAYERS
TABLE 62 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION)
  10.2.1 PRIVATE INSURANCE COMPANIES
    10.2.1.1 Private insurance companies to account for largest market share
TABLE 64 PRIVATE INSURANCE COMPANIES MARKET, BY REGION, 2020–2027 (USD MILLION)
  10.2.2 GOVERNMENT AGENCIES
    10.2.2.1 Increasing use of analytics solutions to boost market
TABLE 65 GOVERNMENT AGENCIES MARKET, BY REGION, 2020–2027 (USD MILLION)
  10.2.3 EMPLOYERS & PRIVATE EXCHANGES
    10.2.3.1 Employers & private exchanges to use data analytics for rapid data integration, health plan analysis, and risk modeling
TABLE 66 EMPLOYERS & PRIVATE EXCHANGES MARKET, BY REGION, 2020–2027 (USD MILLION)
10.3 PROVIDERS
TABLE 67 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
    10.3.1.1 Adoption of healthcare analytics solutions to drive growth
TABLE 68 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS MARKET, BY REGION, 2020–2027 (USD MILLION)
  10.3.2 POST-ACUTE CARE ORGANIZATIONS
    10.3.2.1 Post-acute care organizations to review and study patient data using healthcare analytics
TABLE 69 POST-ACUTE CARE ORGANIZATIONS MARKET, BY REGION,2020–2027 (USD MILLION)
  10.3.3 AMBULATORY SETTINGS
    10.3.3.1 Management of population health and need to control healthcare costs to support market
TABLE 70 AMBULATORY SETTINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.4 ACOS, HIES, MCOS, AND TPAS
TABLE 71 HEALTHCARE ANALYTICS MARKET FOR ACOS, HIES, MCOS, AND TPAS, BY REGION, 2020–2027 (USD MILLION)

11 HEALTHCARE ANALYTICS MARKET, BY REGION

11.1 INTRODUCTION
TABLE 72 HEALTHCARE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 31 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
TABLE 73 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 76 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
TABLE 77 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 80 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 82 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 83 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 84 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.2.1 US
    11.2.1.1 High adoption of EHRs to drive market
TABLE 85 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 87 US: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 US: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 US: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 90 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 91 US: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 US: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 93 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 94 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 US: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.2.2 CANADA
    11.2.2.1 Need for managing patient volumes, clinical data, and healthcare costs to fuel market
TABLE 96 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 98 CANADA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 CANADA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 CANADA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 102 CANADA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 CANADA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 104 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 105 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
11.3 EUROPE
FIGURE 32 EUROPE: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
TABLE 107 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 108 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027(USD MILLION)
TABLE 109 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 110 EUROPE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 EUROPE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 EUROPE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 114 EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 116 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 117 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.3.1 GERMANY
    11.3.1.1 Government initiatives to increase use of analytics in healthcare
TABLE 119 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 121 GERMANY: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
TABLE 122 GERMANY: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 GERMANY: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 125 GERMANY: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 GERMANY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 127 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 128 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.3.2 UK
    11.3.2.1 Availability of venture capital investments to drive market
TABLE 130 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 132 UK: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 UK: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 UK: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 136 UK: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 UK: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 138 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 139 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 UK: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.3.3 FRANCE
    11.3.3.1 Strong financial support for digital health to augment market
TABLE 141 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 143 FRANCE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 FRANCE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 FRANCE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 147 FRANCE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 FRANCE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 149 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 150 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.3.4 REST OF EUROPE
TABLE 152 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 154 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
TABLE 155 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 156 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 157 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 158 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 160 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 161 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
11.4 ASIA
FIGURE 33 ASIA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
TABLE 163 ASIA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 164 ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 166 ASIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 167 ASIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
TABLE 168 ASIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 170 ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 172 ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 173 ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.4.1 JAPAN
    11.4.1.1 Rise in geriatric population to demand effective patient management solutions
TABLE 175 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 177 JAPAN: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 JAPAN: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 JAPAN: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 181 JAPAN: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 JAPAN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 183 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 184 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.4.2 CHINA
    11.4.2.1 Favorable reforms and growing number of EHRs to aid market
TABLE 186 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 187 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 188 CHINA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 CHINA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 CHINA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 192 CHINA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 CHINA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 194 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 195 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.4.3 INDIA
    11.4.3.1 Low healthcare expenditure by government and slow adoption of healthcare analytics solutions to restrain market
TABLE 197 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 199 INDIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 INDIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 INDIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 203 INDIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 INDIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 205 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 206 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 207 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
  11.4.4 REST OF ASIA
TABLE 208 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 209 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 210 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 214 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 216 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 217 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
11.5 PACIFIC COUNTRIES

  11.5.1 NEED TO REDUCE HEALTHCARE COSTS IN AUSTRALIA AND NEW ZEALAND TO DRIVE MARKET
TABLE 219 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 220 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 221 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 222 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
TABLE 223 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 224 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 225 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 226 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 227 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 228 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 229 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
11.6 LATIN AMERICA
  11.6.1 GROWING E-HEALTH INITIATIVES TO PROPEL MARKET
TABLE 230 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 231 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 232 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 233 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 234 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 235 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 236 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 237 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 238 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 239 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 240 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
11.7 MIDDLE EAST & AFRICA
  11.7.1 HIGH HEALTHCARE EXPENDITURE AND INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET
TABLE 241 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
TABLE 245 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 246 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 247 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 248 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
TABLE 249 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 250 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 251 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE

12.1 INTRODUCTION
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
  12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET
12.4 MARKET RANKING ANALYSIS, 2021
FIGURE 35 HEALTHCARE ANALYTICS MARKET RANKING ANALYSIS, 2021
12.5 COMPANY LEADERSHIP MAPPING
  12.5.1 STARS
  12.5.2 PERVASIVE PLAYERS
  12.5.3 EMERGING LEADERS
  12.5.4 PARTICIPANTS
FIGURE 36 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
12.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2021)
  12.6.1 PROGRESSIVE COMPANIES
  12.6.2 STARTING BLOCKS
  12.6.3 RESPONSIVE COMPANIES
  12.6.4 DYNAMIC COMPANIES
FIGURE 37 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
12.7 COMPETITIVE BENCHMARKING
FIGURE 38 OVERALL FOOTPRINT OF COMPANIES (17 COMPANIES)
TABLE 252 APPLICATION FOOTPRINT OF COMPANIES
TABLE 253 END-USER FOOTPRINT OF COMPANIES
TABLE 254 REGIONAL FOOTPRINT OF COMPANIES
12.8 COMPETITIVE SCENARIO
  12.8.1 PRODUCT LAUNCHES & APPROVALS
TABLE 255 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–OCTOBER 2022
  12.8.2 DEALS
TABLE 256 DEALS, JANUARY 2019–OCTOBER 2022
  12.8.3 OTHER DEVELOPMENTS
TABLE 257 OTHER DEVELOPMENTS, JANUARY 2019–OCTOBER 2022

13 COMPANY PROFILES

(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
13.1 KEY PLAYERS
  13.1.1 IBM
TABLE 258 IBM: COMPANY OVERVIEW
FIGURE 39 IBM: COMPANY SNAPSHOT (2021)
  13.1.2 SAS INSTITUTE INC.
TABLE 259 SAS INSTITUTE INC.: COMPANY OVERVIEW
FIGURE 40 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2021)
  13.1.3 OPTUM, INC.
TABLE 260 OPTUM, INC.: COMPANY OVERVIEW
FIGURE 41 OPTUM, INC.: COMPANY SNAPSHOT (2021)
  13.1.4 CERNER CORPORATION
TABLE 261 CERNER CORPORATION: COMPANY OVERVIEW
FIGURE 42 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
  13.1.5 ALLSCRIPTS HEALTHCARE, LLC
TABLE 262 ALLSCRIPTS HEALTHCARE, LLC: COMPANY OVERVIEW
FIGURE 43 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
  13.1.6 COTIVITI, INC.
TABLE 263 COTIVITI, INC.: COMPANY OVERVIEW
  13.1.7 CITIUSTECH INC.
TABLE 264 CITIUSTECH INC.: COMPANY OVERVIEW
  13.1.8 HEALTH CATALYST
TABLE 265 HEALTH CATALYST: COMPANY OVERVIEW
FIGURE 44 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
  13.1.9 CVS HEALTH
TABLE 266 CVS HEALTH: COMPANY OVERVIEW
FIGURE 45 CVS HEALTH: COMPANY SNAPSHOT (2021)
  13.1.10 INOVALON
TABLE 267 INOVALON: COMPANY OVERVIEW
FIGURE 46 INOVALON: COMPANY SNAPSHOT (2021)
  13.1.11 MCKESSON CORPORATION
TABLE 268 MCKESSON CORPORATION: COMPANY OVERVIEW
FIGURE 47 MCKESSON CORPORATION.: COMPANY SNAPSHOT (2021)
  13.1.12 MEDEANALYTICS, INC.
TABLE 269 MEDEANALYTICS, INC.: COMPANY OVERVIEW
  13.1.13 ORACLE
TABLE 270 ORACLE: COMPANY OVERVIEW
FIGURE 48 ORACLE: COMPANY SNAPSHOT (2022)
  13.1.14 EXLSERVICE HOLDINGS, INC.
TABLE 271 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW
FIGURE 49 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2021)
  13.1.15 GAINWELL.
TABLE 272 GAINWELL: COMPANY OVERVIEW
  13.1.16 WIPRO
TABLE 273 WIPRO: COMPANY OVERVIEW
FIGURE 50 WIPRO: COMPANY SNAPSHOT (2022)
13.2 OTHER PLAYERS
  13.2.1 FLATIRON
TABLE 274 FLATIRON: COMPANY OVERVIEW
  13.2.2 APIXIO
TABLE 275 APIXIO: COMPANY OVERVIEW
  13.2.3 ENLITIC, INC.
TABLE 276 ENLITIC, INC.: COMPANY OVERVIEW
  13.2.4 KOMODO HEALTH, INC.
TABLE 277 KOMODO HEALTH, INC.: COMPANY OVERVIEW
  13.2.5 HEALTHEC, LLC
TABLE 278 HEALTHEC, LLC: COMPANY OVERVIEW
  13.2.6 SEMA4 OPCO, INC.
  13.2.7 EVIDATION HEALTH, INC.
  13.2.8 INSILICO MEDICINE
  13.2.9 EXSCIENTIA
  13.2.10 AETION, INC.
  13.2.11 PREMIER
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS


More Publications